Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

The FDA approved a new Pfizer drug for hair loss in teens.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Upadacitinib effectively treats severe alopecia areata and is safe.

Vorasidenib can cause unusual hair growth.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Baricitinib is effective and safe for treating severe alopecia areata.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Voriconazole can cause serious side effects, especially in long-term use.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

ATP helps prevent skin damage from vandetanib by reducing stress.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.